Screener / SEC EDGAR /CIK 0001014739 /10-K filed Feb 24, 2026, compared with Feb 26, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Health care · Home Health Care Services

Option Care Health, Inc. OPCH

Compare with peers Embed
Earnings releases

Latest results release: Nov 4, 2026

8-K item 2.02, exhibit 99

What OPCH's management wrote with each quarter's results: the press release and, when the company files them, its prepared remarks or the call transcript. The call itself is not filed with SEC, so most quarters have the release only.

Adjusted vs GAAP earnings per share

In the company's own words · read from each release, never computed

In its release of Nov 4, 2026, OPCH reported $0.38 per share under GAAP and $0.49 on its own adjusted basis: the adjusted number is +29% above GAAP.

GAAP EPS $0.33, release Jan 13, 2025: 19.2% to 20.1% growth over the fourth quarter of 2023 · Net income of approximately $56.8 to $60.9 million, or diluted earnings per share of $0.33 to $0.36 · Adjusted net income of appro Adjusted EPS $0.42, release Jan 13, 2025: per share of $0.33 to $0.36 · Adjusted net income of approximately $71.0 million to $76.8 million, or adjusted diluted earnings per share of $0.42 to $0.45 Adjusted EBITDA of approximate +27% 2025-01 GAAP EPS $0.35, release Feb 26, 2025: Net income of $60.1 million, compared to net income of $57.2 million, in the fourth quarter of 2023 and diluted earnings per share of $0.35, up 9.4% compared to diluted earnings per share of $0.32 in the fourth quarter of 2023 Adjusted EPS $0.44, release Feb 26, 2025: income of $75.5 million, compared to adjusted net income of $66.7 million in the fourth quarter of 2023 and adjusted diluted earnings per share of $0.44, up 15.8% compared to adjusted diluted +26% 2025-02 GAAP EPS $0.28, release Apr 29, 2025: Net income of $46.7 million, compared to net income of $44.8 million, in the first quarter of 2024 and diluted earnings per share of $0.28, up 7.7% compared to diluted earnings per share of $0.26 in the first quarter of 2024 Adjusted EPS $0.40, release Apr 29, 2025: income of $67.1 million, compared to adjusted net income of $61.6 million in the first quarter of 2024 and adjusted diluted earnings per share of $0.40, up 14.3% compared to adjusted diluted +43% 2025-04 GAAP EPS $0.31, release Jul 30, 2025: Net income of $50.5 million, compared to net income of $53.0 million, in the second quarter of 2024 and diluted earnings per share of $0.31, up 3.3% compared to diluted earnings per share of $0.30 in the second quarter of 2024 Adjusted EPS $0.41, release Jul 30, 2025: of $67.5 million, compared to adjusted net income of $64.9 million, in the second quarter of 2024 and adjusted diluted earnings per share of $0.41, up 10.8% compared to adjusted diluted +32% 2025-07 GAAP EPS $0.32, release Oct 30, 2025: GAAP diluted earnings per share of $0.32, up 3.2% Adjusted EPS $0.45, release Oct 30, 2025: Adjusted diluted earnings per share of $0.45, up 9.8% +41% 2025-10 GAAP EPS $0.37, release Jan 12, 2026: Results · Net revenue of $1.46 billion to $1.47 billion · GAAP net income of $59.1 million to $62.4 million · GAAP diluted EPS of $0.37 to $0.39 · Adjusted diluted EPS of $0.4 Adjusted EPS $0.46, release Jan 12, 2026: to $1.47 billion · GAAP net income of $59.1 million to $62.4 million · GAAP diluted EPS of $0.37 to $0.39 · Adjusted diluted EPS of $0.46 to $0.49 · Adjusted EBITDA of $123.7 mi +24% 2026-01 GAAP EPS $0.37, release Feb 24, 2026: GAAP diluted earnings per share of $0.37, up 5.7% Adjusted EPS $0.46, release Feb 24, 2026: Adjusted diluted earnings per share of $0.46, up 4.5% +24% 2026-02 GAAP EPS $0.29, release Apr 30, 2026: otherwise noted) · Net revenue of $1,350.7 million, up 1.3% · GAAP Net income of $45.3 million, down 3.0% · GAAP diluted earnings per share of $0.29, up 3.6% · Adjusted EBITDA of $104.8 mi Adjusted EPS $0.40, release Apr 30, 2026: 3.0% · GAAP diluted earnings per share of $0.29, up 3.6% · Adjusted EBITDA of $104.8 million, down 6.3% · Adjusted diluted earnings per share of $0.40, flat to the first quarter of 2025 · Ca +38% 2026-04 GAAP EPS $0.35, release Jul 29, 2026: GAAP diluted earnings per share of $0.35, up 12.9% Adjusted EPS $0.45, release Jul 29, 2026: Adjusted diluted earnings per share of $0.45, up 9.8% +29% 2026-07 GAAP EPS $0.38, release Nov 4, 2026: GAAP diluted earnings per share of $0.38, up 18.8% Adjusted EPS $0.49, release Nov 4, 2026: Adjusted diluted earnings per share of $0.49, up 8.9% +29% 2026-11
GAAP EPSAdjusted EPS, as the company defines itThe figure on top is how far adjusted is from GAAP. Click a bar for the sentence.
The company's words, latest release
GAAP diluted earnings per share of $0.38, up 18.8% release
Adjusted diluted earnings per share of $0.49, up 8.9% release

What the company says its adjusted numbers leave out:

(2) Beginning with the three months ended September 30, 2025, adjusted net income excludes loss on extinguishment of debt on a prospective basis, which has been immaterial in prior periods. release Nov 4, 2026

Both numbers are read from the words of each release (usually the highlights), never computed by us; hover a number for its sentence. Quarters where the release gives them only in a table are not shown. The company decides what "adjusted" leaves out; the full reconciliation is in the release.

Read and search

Every release, in full · linked to sec.gov

Press release Nov 4, 2026 · EX-99.1

OPTION CARE HEALTH ANNOUNCES FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED

Open on SEC

OPTION CARE HEALTH ANNOUNCES FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2026

- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today financial results for the third quarter ended September 30, 2026.

As previously announced, the Company has entered into a definitive merger agreement pursuant to which it will be acquired by Clayton, Dubilier & Rice, LLC and McKesson Corporation. Given the pending acquisition, the Company will not host an earnings conference call in connection with these results and has withdrawn its previously disclosed financial guidance.

Option Care Health is the nation’s largest independent provider of home and alternate site infusion services. With over 8,000 team members, including more than 5,000 clinicians, we work compassionately to elevate standards of care for patients with acute and chronic conditions in all 50 states. Through our clinical leadership, expertise and national scale, Option Care Health is reimagining the infusion care experience for patients, customers and team members. To learn more, please visit our website at optioncarehealth.com.

Bob Okunski Vice President, Investor Relations [email protected]

This press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as: “anticipate,” “intend,” “plan,” “believe,” “project,” “estimate,” “expect,” “may,” “should,” “will” and similar references to future periods. Examples of forward-looking statements include, among others, statements the Company may make regarding the acquisition, future revenues, future earnings, other future financial results, regulatory developments, market developments, new products and growth strategies and the effects of any of the foregoing on its future results of operations or financial condition.

Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on the Company's current beliefs, expectations and assumptions regarding the future of its business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of the Company's control. The Company's actual results and financial condition may differ materially from those indicated in the forward-looking statements. Important factors that could cause the Company's actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following: the termination of or occurrence of any event, change or other circumstances that could give rise to the termination of the merger agreement, including circumstances requiring the Company to pay a termination fee pursuant to the merger agreement, or the inability to complete the proposed transaction on the anticipated terms and timetable; the inability to complete the proposed transaction due to the failure to obtain approval of the stockholders of the Company or to satisfy any other condition to closing in a timely manner or at all, or the risk that a regulatory approval that may be required for the proposed transaction is delayed, is not obtained or is obtained subject to conditions that are not anticipated; costs related to the proposed transaction, including from potential litigation relating to the proposed transaction; the risk that restrictions on the operation of the Company’s business during the pendency of the proposed transaction may impact the Company’s ability to pursue certain business opportunities or strategic transactions or undertake certain actions the Company might otherwise have taken; the risk that any announcements relating to the proposed transaction could have adverse effects on the market price of the Company’s common stock, credit ratings or operating results; the risk that the proposed transaction and its announcement could have an adverse effect on the ability of the Company to retain and hire key personnel, retain customers and maintain relationships with business partners, suppliers and customers; the diversion of management’s time and attention from ordinary course business operations to completion of the proposed transaction; changes in laws, regulations or trade policies applicable to its business model; loss of relationships with managed care organizations and other non-governmental third party payers; changes in the pharmaceutical industry, including limiting or discontinuing research, development, production and marketing of pharmaceuticals compatible with its services; changes in market conditions and receptivity to its services and offerings; and pending and future litigation or potential liability for claims not covered by insurance. The foregoing review of important factors should not be construed as exhaustive. Additional information concerning risks, uncertainties and assumptions can be found in the Company’s filings with the SEC, including the risk factors discussed in the Company’s most recent Annual Report on Form 10-K, as updated by the Company’s Quarterly Reports on Form 10-Q and future filings with the SEC.

Any forward-looking statement made by the Company in this press release is based only on information currently available to it and speaks only as of the date on which it is made. The Company undertakes no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

In addition to reporting financial information in accordance with generally accepted accounting principles (GAAP), the Company is also reporting Adjusted net income, Adjusted EBITDA and Adjusted diluted earnings per share ("EPS"), which are non-GAAP financial measures. These adjusted measures are not measurements of financial performance under GAAP and should not be used in isolation or as a substitute or alternative to net income, EPS, or any other performance measure derived in accordance with GAAP, or as a substitute or alternative to cash flow from operating activities or a measure of the Company’s liquidity. In addition, the Company's definitions of Adjusted net income, Adjusted EBITDA, and Adjusted diluted EPS may not be comparable to similarly titled non-GAAP financial measures reported by other companies. As defined by the Company: (i) Adjusted net income represents net income before intangible asset amortization expense, stock-based compensation expense, loss on extinguishment of debt, and restructuring, acquisition, integration and other expenses, net of tax adjustments, (ii) Adjusted EBITDA represents net income before net interest expense, income tax expense, depreciation and amortization, stock-based compensation expense, loss on extinguishment of debt, and restructuring, acquisition, integration and other expenses, and (iii) Adjusted diluted EPS represents Adjusted net income divided by weighted average common shares outstanding, diluted. As part of restructuring, acquisition, integration and other expenses, the Company may incur significant charges such as the write down of certain long‑lived assets, temporary redundant expenses, professional fees, certain litigation expenses and reserves related to acquired businesses, potential retention and severance costs and potential accelerated payments or termination costs for certain of its contractual obligations. Management believes that these adjusted measures provide useful supplemental information regarding the performance of Option Care Health’s business operations and facilitate comparisons to the Company’s historical operating results. The Company has not reconciled Adjusted EBITDA guidance to net income or Adjusted diluted EPS guidance to GAAP diluted EPS as management believes creation of this reconciliation would not be practicable due to the uncertainty regarding, and potential variability of, material reconciling items. Full reconciliations of each historical adjusted measure to the most comparable GAAP financial measure are set forth below. Schedule 1

September 30, 2026 December 31, 2025 ────────────────────────────────────────────────────────────────────────────── ASSETS CURRENT ASSETS: Cash and cash equivalents $ 299,093 $ 232,624 Accounts receivable, net 505,568 473,566 Inventories 408,045 471,149 Prepaid expenses and other current 99,385 87,629 assets Total current assets 1,312,091 1,264,968 NONCURRENT ASSETS: Property and equipment, net 139,035 139,236 Intangible assets, net 19,394 21,897 Referral sources, net 261,975 287,281 Goodwill 1,606,743 1,606,743 Other noncurrent assets 137,029 135,644 Total noncurrent assets 2,164,176 2,190,801 TOTAL ASSETS $ 3,476,267 $ 3,455,769 LIABILITIES AND STOCKHOLDERS’ EQUITY CURRENT LIABILITIES: Accounts payable $ 670,676 $ 639,829 Other current liabilities 179,854 189,519 Total current liabilities 850,530 829,348 NONCURRENT LIABILITIES: Long-term debt, net of discount, deferred financing costs 1,151,054 1,154,052 and current portion Other noncurrent 150,205 145,976 liabilities Total noncurrent 1,301,259 1,300,028 liabilities Total liabilities 2,151,789 2,129,376 STOCKHOLDERS' EQUITY 1,324,478 1,326,393 TOTAL LIABILITIES AND STOCKHOLDERS' $ 3,476,267 $ 3,455,769 EQUITY

Nine Months Ended CASH FLOWS FROM September 30, OPERATING ACTIVITIES: 2026 2025 ────────────────────────────────────────────────────────────────────────────── Net income $ 156,689 $ 149,081 Adjustments to reconcile net income to net cash provided by operating activities: Depreciation and 52,874 50,374 amortization expense Other non-cash 54,243 57,401 adjustments Changes in operating assets and liabilities: Accounts receivable, -32,002 -55,430 net Inventories 63,104 -24,899 Prepaid expenses and other current -14,933 24,694 assets Accounts payable 31,824 10,224 Accrued compensation and employee -8,069 8,338 benefits Other -17,518 2,773 Net cash provided by operating 286,212 222,556 activities CASH FLOWS FROM INVESTING ACTIVITIES: Acquisition of -26,805 -27,661 property and equipment Business acquisitions, net of cash — -117,247 acquired Other investing -877 -2,529 activities Net cash used in -27,682 -147,437 investing activities CASH FLOWS FROM FINANCING ACTIVITIES: Purchase of company stock and related -170,545 -214,887 excise taxes Proceeds from issuance — 229,472 of debt Retirement of debt — -180,239 obligations Other financing -21,516 -12,208 activities Net cash used in -192,061 -177,862 financing activities NET INCREASE (DECREASE) IN CASH AND 66,469 -102,743 CASH EQUIVALENTS Cash and cash equivalents - 232,624 412,565 beginning of period CASH AND CASH EQUIVALENTS - END OF $ 299,093 $ 309,822 PERIOD

(1) Restructuring, acquisition, integration and other includes $5,640 and $13,796 of operating expenses for the three and nine months ended September 30, 2026, respectively. Restructuring, acquisition, integration and other includes $4,634 and $12,570 of operating expenses for the three and nine months ended September 30, 2025, respectively.

(2) Beginning with the three months ended September 30, 2025, adjusted net income excludes loss on extinguishment of debt on a prospective basis, which has been immaterial in prior periods.

(3) Tax adjustments for the three and nine months ended September 30, 2026 and 2025 include the estimated income tax effect on non-GAAP adjustments based on the effective tax rate.

Full text with the tables
                                                                                
  Exhibit 99.1                                                                  
                                                                                
   OPTION CARE HEALTH ANNOUNCES FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED   
                               SEPTEMBER 30, 2026                               
                                                                                
  BANNOCKBURN, IL., November 4, 2026                                            
                                                                                
- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq:
OPCH), the nation’s largest independent provider of home and alternate site
infusion services, announced today financial results for the third quarter ended
September 30, 2026.
                                                                                
  Third Quarter 2026 Financial Highlights                                       
                                                                                
(year-over-year comparisons unless otherwise noted)

• Net revenue of $1,493.5 million, up 4.1%

• GAAP net income of $57.4 million, up 10.8%

• GAAP diluted earnings per share of $0.38, up 18.8%

• Adjusted EBITDA of $124.6 million, up 4.3%

• Adjusted diluted earnings per share of $0.49, up 8.9%

• Cash provided by Q3 operating activities of $114.7 million

As previously announced, the Company has entered into a definitive merger
agreement pursuant to which it will be acquired by Clayton, Dubilier & Rice, LLC
and McKesson Corporation. Given the pending acquisition, the Company will not
host an earnings conference call in connection with these results and has
withdrawn its previously disclosed financial guidance.
                                                                                
  About Option Care Health                                                      
                                                                                
Option Care Health is the nation’s largest independent provider of home and
alternate site infusion services. With over 8,000 team members, including more
than 5,000 clinicians, we work compassionately to elevate standards of care for
patients with acute and chronic conditions in all 50 states. Through our
clinical leadership, expertise and national scale, Option Care Health is
reimagining the infusion care experience for patients, customers and team
members. To learn more, please visit our website at optioncarehealth.com.
                                                                                
  Investor Contact                                                              
                                                                                
                                      
  Bob Okunski                         
  Vice President, Investor Relations  
  [email protected]   
                                      
                                                                                
  Forward-Looking Statements - Safe Harbor                                      
                                                                                
This press release contains “forward-looking statements” within the meaning of
the safe harbor provisions of the U.S. Private Securities Litigation Reform Act
of 1995. Forward-looking statements can be identified by words such as:
“anticipate,” “intend,” “plan,” “believe,” “project,” “estimate,” “expect,”
“may,” “should,” “will” and similar references to future periods. Examples of
forward-looking statements include, among others, statements the Company may
make regarding the acquisition, future revenues, future earnings, other future
financial results, regulatory developments, market developments, new products
and growth strategies and the effects of any of the foregoing on its future
results of operations or financial condition.

Forward-looking statements are neither historical facts nor assurances of future
performance. Instead, they are based only on the Company's current beliefs,
expectations and assumptions regarding the future of its business, future plans
and strategies, projections, anticipated events and trends, the economy and
other future conditions. Because forward-looking statements relate to the
future, they are subject to inherent uncertainties, risks and changes in
circumstances that are difficult to predict and many of which are outside of the
Company's control. The Company's actual results and financial condition may
differ materially from those indicated in the forward-looking statements.
Important factors that could cause the Company's actual results and financial
condition to differ materially from those indicated in the forward-looking
statements include, among others, the following: the termination of or
occurrence of any event, change or other circumstances that could give rise to
the termination of the merger agreement, including circumstances requiring the
Company to pay a termination fee pursuant to the merger agreement, or the
inability to complete the proposed transaction on the anticipated terms and
timetable; the inability to complete the proposed transaction due to the failure
to obtain approval of the stockholders of the Company or to satisfy any other
condition to closing in a timely manner or at all, or the risk that a regulatory
approval that may be required for the proposed transaction is delayed, is not
obtained or is obtained subject to conditions that are not anticipated; costs
related to the proposed transaction, including from potential litigation
relating to the proposed transaction; the risk that restrictions on the
operation of the Company’s business during the pendency of the proposed
transaction may impact the Company’s ability to pursue certain business
opportunities or strategic transactions or undertake certain actions the Company
might otherwise have taken; the risk that any announcements relating to the
proposed transaction could have adverse effects on the market price of the
Company’s common stock, credit ratings or operating results; the risk that the
proposed transaction and its announcement could have an adverse effect on the
ability of the Company to retain and hire key personnel, retain customers and
maintain relationships with business partners, suppliers and customers; the
diversion of management’s time and attention from ordinary course business
operations to completion of the proposed transaction; changes in laws,
regulations or trade policies applicable to its business model; loss of
relationships with managed care organizations and other non-governmental third
party payers; changes in the pharmaceutical industry, including limiting or
discontinuing research, development, production and marketing of pharmaceuticals
compatible with its services; changes in market conditions and receptivity to
its services and offerings; and pending and future litigation or potential
liability for claims not covered by insurance. The foregoing review of important
factors should not be construed as exhaustive. Additional information concerning
risks, uncertainties and assumptions can be found in the Company’s filings with
the SEC, including the risk factors discussed in the Company’s most recent
Annual Report on Form 10-K, as updated by the Company’s Quarterly Reports on
Form 10-Q and future filings with the SEC.

Any forward-looking statement made by the Company in this press release is based
only on information currently available to it and speaks only as of the date on
which it is made. The Company undertakes no obligation to publicly update any
forward-looking statement, whether written or oral, that may be made from time
to time, whether as a result of new information, future developments or
otherwise.
                                                                                
  Note Regarding Use of Non-GAAP Financial Measures                             
                                                                                
In addition to reporting financial information in accordance with generally
accepted accounting principles (GAAP), the Company is also reporting Adjusted
net income, Adjusted EBITDA and Adjusted diluted earnings per share ("EPS"),
which are non-GAAP financial measures. These adjusted measures are not
measurements of financial performance under GAAP and should not be used in
isolation or as a substitute or alternative to net income, EPS, or any other
performance measure derived in accordance with GAAP, or as a substitute or
alternative to cash flow from operating activities or a measure of the Company’s
liquidity. In addition, the Company's definitions of Adjusted net income,
Adjusted EBITDA, and Adjusted diluted EPS may not be comparable to similarly
titled non-GAAP financial measures reported by other companies. As defined by
the Company: (i) Adjusted net income represents net income before intangible
asset amortization expense, stock-based compensation expense, loss on
extinguishment of debt, and restructuring, acquisition, integration and other
expenses, net of tax adjustments, (ii) Adjusted EBITDA represents net income
before net interest expense, income tax expense, depreciation and amortization,
stock-based compensation expense, loss on extinguishment of debt, and
restructuring, acquisition, integration and other expenses, and (iii) Adjusted
diluted EPS represents Adjusted net income divided by weighted average common
shares outstanding, diluted. As part of restructuring, acquisition, integration
and other expenses, the Company may incur significant charges such as the write
down of certain long‑lived assets, temporary redundant expenses, professional
fees, certain litigation expenses and reserves related to acquired businesses,
potential retention and severance costs and potential accelerated payments or
termination costs for certain of its contractual obligations. Management
believes that these adjusted measures provide useful supplemental information
regarding the performance of Option Care Health’s business operations and
facilitate comparisons to the Company’s historical operating results. The
Company has not reconciled Adjusted EBITDA guidance to net income or Adjusted
diluted EPS guidance to GAAP diluted EPS as management believes creation of this
reconciliation would not be practicable due to the uncertainty regarding, and
potential variability of, material reconciling items. Full reconciliations of
each historical adjusted measure to the most comparable GAAP financial measure
are set forth below.
                                                                      Schedule 1
                                                                                
  OPTION CARE HEALTH, INC.                                                      
                                                                                
                                                                                
  CONDENSED CONSOLIDATED BALANCE SHEETS                                         
                                                                                
(IN THOUSANDS)(UNAUDITED)
                                                                                
                                    September 30, 2026       December 31, 2025  
 ────────────────────────────────────────────────────────────────────────────── 
  ASSETS                                                                        
  CURRENT ASSETS:                                                               
  Cash and cash equivalents      $             299,093    $            232,624  
  Accounts receivable, net                     505,568                 473,566  
  Inventories                                  408,045                 471,149  
  Prepaid expenses and other                                                    
  current                                       99,385                  87,629  
  assets                                                                        
  Total current assets                       1,312,091               1,264,968  
  NONCURRENT ASSETS:                                                            
  Property and equipment, net                  139,035                 139,236  
  Intangible assets, net                        19,394                  21,897  
  Referral sources, net                        261,975                 287,281  
  Goodwill                                   1,606,743               1,606,743  
  Other noncurrent assets                      137,029                 135,644  
  Total noncurrent assets                    2,164,176               2,190,801  
  TOTAL ASSETS                   $           3,476,267    $          3,455,769  
  LIABILITIES AND                                                               
  STOCKHOLDERS’ EQUITY                                                          
  CURRENT LIABILITIES:                                                          
  Accounts payable               $             670,676    $            639,829  
  Other current liabilities                    179,854                 189,519  
  Total current liabilities                    850,530                 829,348  
  NONCURRENT LIABILITIES:                                                       
  Long-term debt, net of                                                        
  discount,                                                                     
  deferred financing costs                   1,151,054               1,154,052  
  and current                                                                   
  portion                                                                       
  Other noncurrent                             150,205                 145,976  
  liabilities                                                                   
  Total noncurrent                           1,301,259               1,300,028  
  liabilities                                                                   
  Total liabilities                          2,151,789               2,129,376  
  STOCKHOLDERS' EQUITY                       1,324,478               1,326,393  
  TOTAL LIABILITIES AND                                                         
  STOCKHOLDERS'                  $           3,476,267    $          3,455,769  
  EQUITY                                                                        
                                                                                
                                                                      Schedule 2
                                                                                
  OPTION CARE HEALTH, INC.                                                      
                                                                                
                                                                                
  CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS                                 
                                                                                
(IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)(UNAUDITED)
                                                                                
                    Three                               Nine                    
                   Months                             Months                    
                    Ended                              Ended                    
                  Septem…                            Septem…                    
            2026      30,    2025              2026      30,    2025            
 ────────────────────────────────────────────────────────────────────────────── 
  NET       $     1,493,…    $     1,435,0…    $     4,286,…    $     4,184,0…  
  REVEN…                                                                        
  COST                                                                          
  OF              1,208,…          1,162,1…          3,472,…          3,379,0…  
  REVEN…                                                                        
  GROSS           284,974           272,902          814,239           804,997  
  PROFIT                                                                        
  OPERA…                                                                        
  COSTS                                                                         
  AND                                                                           
  EXPEN…                                                                        
  Selli…                                                                        
  gener…                                                                        
  and             171,998           167,470          503,063           497,744  
  admin…                                                                        
  expen…                                                                        
  Restr…                                                                        
  acqui…                                                                        
  integ…            5,640             4,634           13,796            12,570  
  and                                                                           
  other                                                                         
  Depre…                                                                        
  and              18,120            16,291           50,479            48,278  
  amort…                                                                        
  expen…                                                                        
  Total                                                                         
  opera…          195,758           188,395          567,338           558,592  
  expen…                                                                        
  OPERA…           89,216            84,507          246,901           246,405  
  INCOME                                                                        
  OTHER                                                                         
  INCOME                                                                        
  (EXPE…                                                                        
  Inter…                                                                        
  expen…          -12,875           -14,146          -40,199           -41,824  
  net                                                                           
  Other,            2,560            -1,394            7,189            -3,197  
  net                                                                           
  Total                                                                         
  other           -10,315           -15,540          -33,010           -45,021  
  (expe…                                                                        
  income                                                                        
  INCOME                                                                        
  BEFORE           78,901            68,967          213,891           201,384  
  INCOME                                                                        
  TAXES                                                                         
  INCOME                                                                        
  TAX              21,468            17,151           57,202            52,303  
  EXPEN…                                                                        
  NET       $      57,433    $       51,816    $     156,689    $      149,081  
  INCOME                                                                        
  Earni…                                                                        
  per       $        0.38    $         0.32    $        1.02    $         0.91  
  share,                                                                        
  basic                                                                         
  Earni…                                                                        
  per       $        0.38    $         0.32    $        1.02    $         0.91  
  share,                                                                        
  dilut…                                                                        
  Weigh…                                                                        
  avera…                                                                        
  shares          149,788           161,829          153,099           163,393  
  outst…                                                                        
  basic                                                                         
  Weigh…                                                                        
  avera…                                                                        
  shares          150,491           163,086          153,932           164,602  
  outst…                                                                        
  dilut…                                                                        
                                                                                
                                                                      Schedule 3
                                                                                
  OPTION CARE HEALTH, INC.                                                      
                                                                                
                                                                                
  CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS                               
                                                                                
(IN THOUSANDS)(UNAUDITED)
                                                                                
                            Nine Months Ended                                   
  CASH FLOWS FROM           September 30,                                       
  OPERATING ACTIVITIES:     2026                                2025            
 ────────────────────────────────────────────────────────────────────────────── 
  Net income                $                        156,689    $      149,081  
  Adjustments to                                                                
  reconcile net income                                                          
  to                                                                            
  net cash provided by                                                          
  operating                                                                     
  activities:                                                                   
  Depreciation and                                    52,874            50,374  
  amortization expense                                                          
  Other non-cash                                      54,243            57,401  
  adjustments                                                                   
  Changes in operating                                                          
  assets and                                                                    
  liabilities:                                                                  
  Accounts receivable,                               -32,002           -55,430  
  net                                                                           
  Inventories                                         63,104           -24,899  
  Prepaid expenses and                                                          
  other current                                      -14,933            24,694  
  assets                                                                        
  Accounts payable                                    31,824            10,224  
  Accrued compensation                                                          
  and employee                                        -8,069             8,338  
  benefits                                                                      
  Other                                              -17,518             2,773  
  Net cash provided by                                                          
  operating                                          286,212           222,556  
  activities                                                                    
  CASH FLOWS FROM                                                               
  INVESTING ACTIVITIES:                                                         
  Acquisition of                                     -26,805           -27,661  
  property and equipment                                                        
  Business acquisitions,                                                        
  net of cash                                              —          -117,247  
  acquired                                                                      
  Other investing                                       -877            -2,529  
  activities                                                                    
  Net cash used in                                   -27,682          -147,437  
  investing activities                                                          
  CASH FLOWS FROM                                                               
  FINANCING ACTIVITIES:                                                         
  Purchase of company                                                           
  stock and related                                 -170,545          -214,887  
  excise taxes                                                                  
  Proceeds from issuance                                   —           229,472  
  of debt                                                                       
  Retirement of debt                                       —          -180,239  
  obligations                                                                   
  Other financing                                    -21,516           -12,208  
  activities                                                                    
  Net cash used in                                  -192,061          -177,862  
  financing activities                                                          
  NET INCREASE                                                                  
  (DECREASE) IN CASH AND                              66,469          -102,743  
  CASH                                                                          
  EQUIVALENTS                                                                   
  Cash and cash                                                                 
  equivalents -                                      232,624           412,565  
  beginning of                                                                  
  period                                                                        
  CASH AND CASH                                                                 
  EQUIVALENTS - END OF      $                        299,093    $      309,822  
  PERIOD                                                                        
                                                                                
                                                                      Schedule 4
                                                                                
  OPTION CARE HEALTH, INC.                                                      
                                                                                
QUARTERLY RECONCILIATION BETWEEN GAAP AND NON-GAAP MEASURES

(IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)(UNAUDITED)
                                                                                
                     Three                               Nine                   
                    Months                             Months                   
                     Ended                              Ended                   
                   Septem…                           Septemb…                   
             2026      30,    2025             2026       30,    2025           
 ────────────────────────────────────────────────────────────────────────────── 
  Net        $      57,433    $      51,816    $      156,689    $     149,081  
  income                                                                        
  Intere…                                                                       
  expens…           12,875           14,146            40,199           41,824  
  net                                                                           
  Income                                                                        
  tax               21,468           17,151            57,202           52,303  
  expense                                                                       
  Deprec…                                                                       
  and               18,837           17,048            52,874           50,374  
  amorti…                                                                       
  expense                                                                       
  EBITDA           110,613          100,161           306,964          293,582  
  EBITDA                                                                        
  adjust…                                                                       
  Stock-…                                                                       
  incent…            9,331           11,125            27,912           30,638  
  compen…                                                                       
  expense                                                                       
  Loss on                                                                       
  exting…                —            4,744                 —            4,744  
  of debt                                                                       
  Restru…                                                                       
  acquis…                                                                       
  integr…            4,656            3,468            11,976           16,318  
  and                                                                           
  other                                                                         
  (1)                                                                           
  Adjust…    $     124,600    $     119,498    $      346,852    $     345,282  
  EBITDA                                                                        
  Net        $      57,433    $      51,816    $      156,689    $     149,081  
  income                                                                        
  Intang…                                                                       
  asset              9,269            9,269            27,808           27,663  
  amorti…                                                                       
  expense                                                                       
  Stock-…                                                                       
  incent…            9,331           11,125            27,912           30,638  
  compen…                                                                       
  expense                                                                       
  Loss on                                                                       
  exting…                —            4,744                 —            4,744  
  of debt                                                                       
  (2)                                                                           
  Restru…                                                                       
  acquis…                                                                       
  integr…            4,656            3,468            11,976           16,318  
  and                                                                           
  other                                                                         
  (1)                                                                           
  Total                                                                         
  pre-tax           23,256           28,606            67,696           79,363  
  adjust…                                                                       
  Tax                                                                           
  adjust…           -6,298           -7,183           -18,075          -20,634  
  (3)                                                                           
  Adjust…                                                                       
  net        $      74,391    $      73,239    $      206,310    $     207,810  
  income                                                                        
  Earnin…                                                                       
  per        $        0.38    $        0.32    $         1.02    $        0.91  
  share,                                                                        
  diluted                                                                       
  Adjust…                                                                       
  earnin…                                                                       
  per        $        0.49    $        0.45    $         1.34    $        1.26  
  share,                                                                        
  diluted                                                                       
  Weight…                                                                       
  average                                                                       
  common           150,491          163,086           153,932          164,602  
  shares                                                                        
  outsta…                                                                       
  diluted                                                                       
                                                                                
(1) Restructuring, acquisition, integration and other includes $5,640 and
$13,796 of operating expenses for the three and nine months ended September 30,
2026, respectively. Restructuring, acquisition, integration and other includes
$4,634 and $12,570 of operating expenses for the three and nine months ended
September 30, 2025, respectively.

(2) Beginning with the three months ended September 30, 2025, adjusted net
income excludes loss on extinguishment of debt on a prospective basis, which has
been immaterial in prior periods.

(3) Tax adjustments for the three and nine months ended September 30, 2026 and
2025 include the estimated income tax effect on non-GAAP adjustments based on
the effective tax rate.

Sources

The 8-K item 2.02 filings (SEC EDGAR) and their EX-99 exhibits: the results release and, when filed, prepared remarks or the call transcript.

Also

Said vs did: the targets in these releases against what was then reported. Filings: every filing.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/OPCH/export.csv") into a cell.

Next:Presentations
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.